TABLE 3.
Characteristics of participants <6 months of age, by BCG vaccine scarring status
| Characteristic | Value for participants with BCG lesion
|
Pa | ||
|---|---|---|---|---|
| Scarred (n = 10) | Inflammed (n = 5) | Absent (n = 33) | ||
| Male (%) | 30 | 40 | 79 | 0.009 |
| Median age (yr) | 0.3 | 0.2 | 0.1 | 0.003 |
| Death (no. dead/no. with outcome data) | 1/9 | 0/4 | 4/23 | 0.625 |
| HIV seropositive (%)b | 22 | 60 | 19 | 0.144 |
| Blood culture positive (all Salmonella spp.) (no./total no.) | 0/10 | 0/5 | 8/33 | 0.158 |
| Proven or highly suspected sepsisc (no./total no.) | 0/10 | 0/5 | 18/33 | <0.001 |
| Localized infectiond (no./total no.) | 1/10 | 3/5 | 0/33 | <0.001 |
a
Kruskal-Wallis or chi-square tests.
b
HIV serostatus was not known for one infant with a BCG scar and two infants without BCG lesions.
c
Positive blood culture and/or leukocytosis, abnormal temperature, and organomegally.
d
Including bronchiolitis with possible pneumonia, acute otitis media with suspected meningitis, submandibular cellulitis, and HIV-associated oral candidiasis.